FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Mendelman

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Human Influenza

Procedures

Physiology

Ampicillin Resistance

Co-author Network

Publications

TOP 3
Charles Richardson; Robert F Bargatze; Robert Goodwin; Paul M Mendelman
Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis.
Samer S El-Kamary; Marcela F Pasetti; Paul M Mendelman; Sharon E Frey; David I Bernstein; John J Treanor; Jennifer Ferreira; Wilbur H Chen; Richard Sublett; Charles Richardson; Robert Bargatze; Marcelo B Sztein; Carol O Tacket
Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues.
Terry Nolan; David I Bernstein; Stan L Block; Milo Hilty; Harry L Keyserling; Colin Marchant; Helen Marshall; Peter Richmond; Ram Yogev; Julie M Cordova; Iksung Cho; Paul M Mendelman
Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Mendelman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Charles Richardson; Robert F Bargatze; Robert Goodwin; Paul M Mendelman
Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis.
Expert review of vaccines 2013;12(2):155-67.
2010: Samer S El-Kamary; Marcela F Pasetti; Paul M Mendelman; Sharon E Frey; David I Bernstein; John J Treanor; Jennifer Ferreira; Wilbur H Chen; Richard Sublett; Charles Richardson; Robert Bargatze; Marcelo B Sztein; Carol O Tacket
Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues.
The Journal of infectious diseases 2010;202(11):1649-58.
2008: Terry Nolan; David I Bernstein; Stan L Block; Milo Hilty; Harry L Keyserling; Colin Marchant; Helen Marshall; Peter Richmond; Ram Yogev; Julie M Cordova; Iksung Cho; Paul M Mendelman
Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
Pediatrics 2008;121(3):508-16.
2006: Timo Vesikari; Aino Karvonen; Tiina Korhonen; Kati Edelman; Raija Vainionpää; Aimo A Salmi; Melanie K Saville; Iksung Cho; Ahmad Razmpour; Ruth Rappaport; Robert O'Neill; Alice Georgiu; William C Gruber; Paul M Mendelman; Bruce D Forrest
A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine.
The Pediatric infectious disease journal 2006;25(7):590-5.
2005: David P Greenberg; Robert E Walker; Min-Shi Lee; Keith S Reisinger; Joel I Ward; Ram Yogev; Mark M Blatter; Sylvia H Yeh; Ruth A Karron; Christa Sangli; Lane Eubank; Kathleen L Coelingh; Julie M Cordova; Marilyn J August; Hersh Mehta; Wendy Chen; Paul M Mendelman
A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy.
The Journal of infectious diseases 2005;191(7):1116-22.
2005: Min-Shi Lee; Robert E Walker; Paul M Mendelman
Medical burden of respiratory syncytial virus and parainfluenza virus type 3 infection among US children. Implications for design of vaccine trials.
Human vaccines 2005;1(1):6-11.
2004: Robert B Belshe; Min-Shi Lee; Robert E Walker; Jeffrey J Stoddard; Paul M Mendelman
Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.
Expert review of vaccines 2004;3(6):643-54.
2004: Paul M Mendelman; Ruth Rappaport; Iksung Cho; Stan Block; William C Gruber; Marilyn J August; Denise M Dawson; Julie M Cordova; George W Kemble; Kutubuddin Mahmood; Giuseppe Palladino; Min-Shi Lee; Ahmad Razmpour; Jeffrey J Stoddard; Bruce D Forrest
Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain.
The Pediatric infectious disease journal 2004;23(11):1053-5.
2004: Robert B Belshe; Kristin L Nichol; Steven B Black; Henry Shinefield; Julie M Cordova; Robert E Walker; Colin Hessel; Iksung Cho; Paul M Mendelman
Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(7):920-7.
2004: Min-Shi Lee; Kutubuddin Mahmood; Lopa Adhikary; Marilyn J August; Julie M Cordova; Iksung Cho; George W Kemble; Keith S Reisinger; Robert E Walker; Paul M Mendelman
Measuring antibody responses to a live attenuated influenza vaccine in children.
The Pediatric infectious disease journal 2004;23(9):852-6.
2004: Geoffrey J Gorse; Theresa Z O'Connor; Frances K Newman; Mahendra D Mandava; Paul M Mendelman; Janet Wittes; Peter Peduzzi
Immunity to influenza in older adults with chronic obstructive pulmonary disease.
The Journal of infectious diseases 2004;190(1):11-9.
2004: Kristin L Nichol; Paul M Mendelman
Influence of clinical case definitions with differing levels of sensitivity and specificity on estimates of the relative and absolute health benefits of influenza vaccination among healthy working adults and implications for economic analyses.
Virus research 2004;103(1-2):3-8.
2004: Randy Bergen; Steven Black; Henry Shinefield; Edwin Lewis; Paula Ray; John Hansen; Robert E Walker; Colin Hessel; Julie M Cordova; Paul M Mendelman
Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents.
The Pediatric infectious disease journal 2004;23(2):138-44.
2003: Robert B Belshe; Paul M Mendelman
Safety and efficacy of live attenuated, cold-adapted, influenza vaccine-trivalent.
Immunology and allergy clinics of North America 2003;23(4):745-67.
2003: Kristin L Nichol; Kenneth P Mallon; Paul M Mendelman
Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine.
Vaccine 2003;21(17-18):2207-17.
2003: Geoffrey J Gorse; Theresa Z O'Connor; Stephen L Young; Paul M Mendelman; Suzanne F Bradley; Kristin L Nichol; James H Strickland; Daniel M Paulson; Kathryn L Rice; Runi A Foster; Ashok M Fulambarker; John W Shigeoka; Ware G Kuschner; Richard P Goodman; Kathleen M Neuzil; Janet Wittes; Kathy D Boardman; Peter Peduzzi
Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study.
Vaccine 2003;21(17-18):2133-44.
2003: Kenneth M Zangwill; David P Greenberg; Chung-Yin Chiu; Paul M Mendelman; Victor K Wong; Swei-Ju Chang; Susan Partridge; Joel I Ward
Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants.
Vaccine 2003;21(17-18):1894-900.
2003: Terry Nolan; Min-Shi Lee; Julie M Cordova; Iksung Cho; Robert E Walker; Marilyn J August; Susan Larson; Kathleen L Coelingh; Paul M Mendelman
Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities.
Vaccine 2003;21(11-12):1224-31.
2003: David I Bernstein; Lihan Yan; John Treanor; Paul M Mendelman; Robert B Belshe
Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children.
The Pediatric infectious disease journal 2003;22(1):28-34.
2002: Pedro Piedra; Lihan Yan; Karen L Kotloff; Kenneth M Zangwill; David I Bernstein; James C King; John Treanor; Flor M Munoz; Mark Wolff; Iksung Cho; Paul M Mendelman; Julie M Cordova; Robert B Belshe
Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children.
Pediatrics 2002;110(4):662-72.
2002: Sandra L Watkins; Steven R Alexander; Eileen D Brewer; Teresa M Hesley; David J West; Ivan S F Chan; Paul M Mendelman; Shelia M Bailey; Jane L Burns; Ronald J Hogg
Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;40(2):365-72.
2002: Edwin L Anderson; Sharon Frey; Kathy Geldmacher; David Radley; Ann Lee; John Donnelly; Paul M Mendelman; Jennifer M Dargan; Karen M Kaplan
Safety, tolerability and immunogenicity of low dose Haemophilus influenzae type b conjugated to the outer membrane protein complex of Neisseria meningitidis group B.
The Pediatric infectious disease journal 2002;21(4):350-2.
2002: Gregory J Redding; Robert E Walker; Colin Hessel; Frank S Virant; Garrison H Ayars; George Bensch; Julie M Cordova; Sandra J Holmes; Paul M Mendelman
Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma.
The Pediatric infectious disease journal 2002;21(1):44-8.
2001: Min-Shi Lee; David P Greenberg; Sylvia H Yeh; R Yogev; Keith S Reisinger; Joel I Ward; Mark M Blatter; Iksung Cho; Sandra J Holmes; Julie M Cordova; Marilyn J August; Wendy Chen; Hersh Mehta; Kathleen L Coelingh; Paul M Mendelman
Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants.
The Journal of infectious diseases 2001;184(7):909-13.
2001: Kenneth M Zangwill; J Droge; Paul M Mendelman; S Michael Marcy; Susan Partridge; C Y Chiu; J Jing; Swei-Ju Chang; Iksung Cho; Joel I Ward
Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children.
The Pediatric infectious disease journal 2001;20(8):740-6.
2001: BR Luce; Kenneth M Zangwill; Cynthia S Palmer; Paul M Mendelman; Lihan Yan; M C Wolff; Iksung Cho; S Michael Marcy; D Iacuzio; Robert B Belshe
Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children.
Pediatrics 2001;108(2):E24.
2001: Min-Shi Lee; Paul M Mendelman; Christa Sangli; Iksung Cho; Sharon Mathie; Marilyn J August
Half-life of human parainfluenza virus type 3 (hPIV3) maternal antibody and cumulative proportion of hPIV3 infection in young infants.
The Journal of infectious diseases 2001;183(8):1281-4.
2001: Paul M Mendelman; Julie M Cordova; Iksung Cho
Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults.
Vaccine 2001;19(17-19):2221-6.
2000: Eric Mallet; P Fabre; E Pines; H Salomon; T Staub; Florian Schodel; Paul M Mendelman; Luc Hessel; G Chryssomalis; E Vidor; Agnès Hoffenbach
Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants.
The Pediatric infectious disease journal 2000;19(12):1119-27.
2000: M D Blum; R Dagan; Paul M Mendelman; V Pinsk; M Giordani; Shu Li; N Bohidar; Tessie B McNeely
A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers.
Vaccine 2000;18(22):2359-67.
2000: Ira M Longini; M Elizabeth Halloran; Azhar Nizam; Mark Wolff; Paul M Mendelman; Patricia Fast; Robert B Belshe
Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control.
Vaccine 2000;18(18):1902-9.
2000: Robert B Belshe; William C Gruber; Paul M Mendelman; Hersh Mehta; Kutubuddin Mahmood; Keith S Reisinger; John Treanor; Kenneth M Zangwill; FG Hayden; David I Bernstein; Karen L Kotloff; James C King; Pedro Piedra; S L Block; Lihan Yan; Mark Wolff
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
The Journal of infectious diseases 2000;181(3):1133-7.
2000: Robert B Belshe; William C Gruber; Paul M Mendelman; Iksung Cho; Keith S Reisinger; S L Block; Janet Wittes; D Iacuzio; Pedro Piedra; John Treanor; James C King; Karen L Kotloff; David I Bernstein; FG Hayden; Kenneth M Zangwill; Lihan Yan; Mark Wolff
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.
The Journal of pediatrics 2000;136(2):168-75.
2000: TA Cha; K Kao; Jackie Zhao; Patricia Fast; Paul M Mendelman; A Arvin
Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial.
Journal of clinical microbiology 2000;38(2):839-45.
1999: Kristin L Nichol; Paul M Mendelman; Kenneth P Mallon; Lisa A Jackson; Geoffrey J Gorse; Robert B Belshe; W P Glezen; Janet Wittes
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
JAMA : the journal of the American Medical Association 1999;282(2):137-44.
1999: Lisa A Jackson; Sandra J Holmes; Paul M Mendelman; L Huggins; Iksung Cho; J Rhorer
Safety of a trivalent live attenuated intranasal influenza vaccine, FluMist, administered in addition to parenteral trivalent inactivated influenza vaccine to seniors with chronic medical conditions.
Vaccine 1999;17(15-16):1905-9.
1998: Deborah Lehmann; M Kakazo; S Yarsley; A Javati; John Taime; Gerard Saleu; Pioto Namuigi; Michael P Alpers; Paul M Mendelman; T Staub
Safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine (PedvaxHIB) in Papua New Guinean children.
Papua and New Guinea medical journal 1998;41(3-4):102-11.
1998: Robert B Belshe; Paul M Mendelman; John Treanor; James C King; William C Gruber; Pedro Piedra; David I Bernstein; FG Hayden; Karen L Kotloff; Kenneth M Zangwill; D Iacuzio; Mark Wolff
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
The New England journal of medicine 1998;338(20):1405-12.
1997: Jan Storek; Paul M Mendelman; Robert P Witherspoon; B A McGregor; Rainer Storb
IgG response to pneumococcal polysaccharide-protein conjugate appears similar to IgG response to polysaccharide in bone marrow transplant recipients and healthy adults.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;25(5):1253-5.
1997: Paul M Mendelman; L Feeley; S Bird; T Staub; H Matthews; M A Del Beccaro; G Overturf; A Lee; R Ellis; J Staub; S Szymanski; J Donnelly; John Hennessey; P Kniskern
Immunogenicity and safety of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis conjugate vaccine in 7.5 micrograms liquid formulation: a comparison of three lots with the 15.0 micrograms lyophilized formulation. Study Group for 7.5 micrograms Liquid PedvaxHIB.
Vaccine 1997;15(6-7):775-81.
1996: R Dagan; Rimma Melamed; M Muallem; Lolita Piglansky; David Greenberg; O Abramson; Paul M Mendelman; N Bohidar; P Yagupsky
Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine.
The Journal of infectious diseases 1996;174(6):1271-8.
1996: E L Anderson; D J Kennedy; K M Geldmacher; J Donnelly; Paul M Mendelman
Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants.
The Journal of pediatrics 1996;128(5 Pt 1):649-53.
1995: Lisa G Rider; P B Thapa; Mark A Del Beccaro; J L Gale; H M Foy; J R Farwell; Paul M Mendelman
Cerebrospinal fluid analysis in children with seizures.
Pediatric emergency care 1995;11(4):226-9.
1994: Basim I Asmar; AS Dajani; Mark A Del Beccaro; Paul M Mendelman
Comparison of cefpodoxime proxetil and cefixime in the treatment of acute otitis media in infants and children. Otitis Study Group.
Pediatrics 1994;94(6 Pt 1):847-52.
1994: P W Sheeran; Arnold L. Smith; Paul M Mendelman
The susceptibility of Haemophilus influenzae middle ear and sinus isolates to sulphisoxazole.
The Journal of antimicrobial chemotherapy 1994;33(2):360-3.
1994: J L Gale; P B Thapa; S G Wassilak; JK Bobo; Paul M Mendelman; H M Foy
Risk of serious acute neurological illness after immunization with diphtheria-tetanus-pertussis vaccine. A population-based case-control study.
JAMA : the journal of the American Medical Association 1994;271(1):37-41.
1993: Lisa G Rider; M H Wener; J French; David D Sherry; Paul M Mendelman
Autoantibody production in Kawasaki syndrome.
Clinical and experimental rheumatology 1993;11(4):445-9.
1993: S Yan; Paul M Mendelman; D L Stevens
The in vitro antibacterial activity of ceftriaxone against Streptococcus pyogenes is unrelated to penicillin-binding protein 4.
FEMS microbiology letters 1993;110(3):313-7.
1993: M Burroughs; S Prasad; C Cabellos; Paul M Mendelman; Elaine I Tuomanen
The biologic activities of peptidoglycan in experimental Haemophilus influenzae meningitis.
The Journal of infectious diseases 1993;167(2):464-8.
1992: Mark A Del Beccaro; A N Champoux; T Bockers; Paul M Mendelman
Septic arthritis versus transient synovitis of the hip: the value of screening laboratory tests.
Annals of emergency medicine 1992;21(12):1418-22.
1992: Paul M Mendelman; Mark A Del Beccaro; S E McLinn; W M Todd
Cefpodoxime proxetil compared with amoxicillin-clavulanate for the treatment of otitis media.
The Journal of pediatrics 1992;121(3):459-65.
1992: Mark A Del Beccaro; Paul M Mendelman; A F Inglis; Mark A Richardson; N O Duncan; Richard P Shugerman
Acute-phase reactants and acute bacterial otitis media.
American journal of diseases of children (1960) 1992;146(9):1037-9.
1992: G B Calandra; Paul M Mendelman
Timing of the booster dose with Haemophilus polyribosylribitol phosphate conjugated with Neisseria outer-membrane protein.
The Journal of pediatrics 1992;121(1):172.
1992: Paul M Mendelman
Targets of the beta-lactam antibiotics, penicillin-binding proteins, in ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae.
The Journal of infectious diseases 1992;165 Suppl 1():S107-9.
1992: W D Graf; R M Hays; Susan J Astley; Paul M Mendelman
Electrodiagnosis reliability in the diagnosis of infant botulism.
The Journal of pediatrics 1992;120(5):747-9.
1992: Paul Krogstad; Paul M Mendelman; Virginia L Miller; C Clausen; S Abbott; S Weagant; C L Wilson; D B Lewis
Clinical and microbiologic characteristics of cutaneous infection with Yersinia enterocolitica.
The Journal of infectious diseases 1992;165(4):740-3.
1992: Mark A Del Beccaro; Paul M Mendelman; A F Inglis; Mark A Richardson; N O Duncan; C R Clausen; T L Stull
Bacteriology of acute otitis media: a new perspective.
The Journal of pediatrics 1992;120(1):81-4.
1991: Lorry Rubin; Paul M Mendelman; R M Rakita; H Rosen
Virulence of non-beta-lactamase-mediated ampicillin-resistant Haemophilus influenzae.
FEMS microbiology letters 1991;68(1):27-31.
1991: Lisa G Rider; Paul M Mendelman; J French; David D Sherry
Group A streptococcal infection and Kawasaki syndrome.
Lancet 1991;337(8749):1100-1.
1990: Paul M Mendelman; D O Chaffin; LR Krilov; G Kalaitzoglou; D A Serfass; O Onay; E A Wiley; G D Overturf; Lorry Rubin
Cefuroxime treatment failure of nontypable Haemophilus influenzae meningitis associated with alteration of penicillin-binding proteins.
The Journal of infectious diseases 1990;162(5):1118-23.
1990: Paul M Mendelman; E A Wiley; T L Stull; Carla R Clausen; D O Chaffin; O Onay
Problems with current recommendations for susceptibility testing of Haemophilus influenzae.
Antimicrobial agents and chemotherapy 1990;34(8):1480-4.
1990: JE Mortensen; M LaRocco; S L Himes; C Inderlied; J A Daly; J M Campos; Paul M Mendelman
Antimicrobial susceptibility of clinical isolates of Haemophilus influenzae to ampicillin-sulbactam.
Diagnostic microbiology and infectious disease 1990;13(4):341-4.
1990: Paul M Mendelman; D O Chaffin; G Kalaitzoglou
Penicillin-binding proteins and ampicillin resistance in Haemophilus influenzae.
The Journal of antimicrobial chemotherapy 1990;25(4):525-34.
1989: Paul M Mendelman; L L Henritzy; D O Chaffin; K Lent; Arnold L. Smith; T L Stull; E A Wiley
In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae.
Antimicrobial agents and chemotherapy 1989;33(11):1878-82.
1989: Paul M Mendelman; D O Chaffin
PBP profiles of Haemophilus influenzae, H. aegyptius, and the H. influenzae biogroup aegyptius associated with Brazilian Purpuric Fever.
Diagnostic microbiology and infectious disease 1989;12(5):445-7.
1989: L K McDonald; T A Tartaglione; Paul M Mendelman; K E Opheim; Lawrence Corey
Lack of toxicity in two cases of neonatal acyclovir overdose.
The Pediatric infectious disease journal 1989;8(8):529-32.
1989: J B Cologne; Paul M Mendelman; D O Chaffin
Statistical comparison of ligand-binding kinetics.
Statistics in medicine 1989;8(7):871-81.
1989: Mark A Del Beccaro; Paul M Mendelman; C Nolan
Diagnostic usefulness of mycobacterial skin test antigens in childhood lymphadenitis.
The Pediatric infectious disease journal 1989;8(4):206-10.
1989: Paul M Mendelman; Dominique A Caugant; G Kalaitzoglou; Elisabeth Wedege; D O Chaffin; J Campos; J A Saez-Nieto; Marc Viñas; R K Selander
Genetic diversity of penicillin G-resistant Neisseria meningitidis from Spain.
Infection and immunity 1989;57(4):1025-9.
1989: R L Davis; Paul M Mendelman; B Ramsey; Arnold L. Smith
Tobramycin dosage recommendation in patients with cystic fibrosis.
Infection 1989;17(1):41.
1988: Paul M Mendelman; D A Serfass
The penicillin binding proteins of the genus Haemophilus.
Journal of medical microbiology 1988;27(2):95-8.
1988: M L Morse; Daniel J Karr; Paul M Mendelman
Ocular tuberculosis in a five-month-old.
The Pediatric infectious disease journal 1988;7(7):514-6.
1988: Paul M Mendelman; J Campos; D O Chaffin; D A Serfass; Arnold L. Smith; J A Sáez-Nieto
Relative penicillin G resistance in Neisseria meningitidis and reduced affinity of penicillin-binding protein 3.
Antimicrobial agents and chemotherapy 1988;32(5):706-9.
1987: Paul M Mendelman; D O Chaffin; J M Musser; R De Groot; D A Serfass; R K Selander
Genetic and phenotypic diversity among ampicillin-resistant, non-beta-lactamase-producing, nontypeable Haemophilus influenzae isolates.
Infection and immunity 1987;55(11):2585-9.
1987: E J Rich; Paul M Mendelman
Acute suppurative thyroiditis in pediatric patients.
The Pediatric infectious disease journal 1987;6(10):936-40.
1987: J Campos; Paul M Mendelman; M U Sako; D O Chaffin; Arnold L. Smith; J A Sáez-Nieto
Detection of relatively penicillin G-resistant Neisseria meningitidis by disk susceptibility testing.
Antimicrobial agents and chemotherapy 1987;31(10):1478-82.
1986: D A Serfass; Paul M Mendelman; D O Chaffin; C A Needham
Ampicillin resistance and penicillin-binding proteins of Haemophilus influenzae.
Journal of general microbiology 1986;132(10):2855-61.
1986: Paul M Mendelman; D O Chaffin; Carla R Clausen; T L Stull; C Needham; J D Williams; Arnold L. Smith
Failure to detect ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae by standard disk susceptibility testing.
Antimicrobial agents and chemotherapy 1986;30(2):274-80.
1986: J Levy; Jane L Burns; Paul M Mendelman; K Wong; K Mack; Arnold L. Smith
Effect of tobramycin on protein synthesis in 2-deoxystreptamine aminoglycoside-resistant clinical isolates of Haemophilus influenzae.
Antimicrobial agents and chemotherapy 1986;29(3):474-81.
1986: Jane L Burns; Craig E Rubens; Paul M Mendelman; Arnold L. Smith
Cloning and expression in Escherichia coli of a gene encoding nonenzymatic chloramphenicol resistance from Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy 1986;29(3):445-50.
1985: Paul M Mendelman; Arnold L. Smith; J Levy; A Weber; B Ramsey; R L Davis
Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum.
The American review of respiratory disease 1985;132(4):761-5.
1985: Paul M Mendelman; V P Syriopoulou; S L Gandy; J I Ward; Arnold L. Smith
Molecular epidemiology of plasmid-mediated ampicillin resistance in Haemophilus influenzae type b isolates from Alaska.
The Journal of infectious diseases 1985;151(6):1061-72.
1985: Jane L Burns; Paul M Mendelman; J Levy; T L Stull; Arnold L. Smith
A permeability barrier as a mechanism of chloramphenicol resistance in Haemophilus influenzae.
Antimicrobial agents and chemotherapy 1985;27(1):46-54.
1984: T L Stull; Paul M Mendelman; J E Haas; M A Schoenborn; K D Mack; Arnold L. Smith
Characterization of Haemophilus influenzae type b fimbriae.
Infection and immunity 1984;46(3):787-96.
1984: Paul M Mendelman; D O Chaffin; T L Stull; Craig E Rubens; K D Mack; Arnold L. Smith
Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae.
Antimicrobial agents and chemotherapy 1984;26(2):235-44.
1984: Paul M Mendelman; C A Doroshow; S L Gandy; V Syriopoulou; C P Weigen; Arnold L. Smith
Plasmid-mediated resistance in multiply resistant Haemophilus influenzae type b causing meningitis: molecular characterization of one strain and review of the literature.
The Journal of infectious diseases 1984;150(1):30-9.
1983: Paul M Mendelman; L D Jankovsky; R S Murray; P Licari; B DeVald; John Gerdes; J S Burks
Pathogenesis of coronavirus SD in mice. I. Prominent demyelination in the absence of infectious virus production.
Archives of neurology 1983;40(8):493-8.
1982: Paul M Mendelman; M C Roberts; Arnold L. Smith
Mutation frequency of Haemophilus influenzae to rifampin resistance.
Antimicrobial agents and chemotherapy 1982;22(3):531-3.
1975: F W Bruhn; Paul M Mendelman; J Amer
Mumps meningoencephalitis. A possible clue to early diagnosis.
Rocky Mountain medical journal 1975;72(8):343-4.